Recent advances on anti-HIV chimeric antigen receptor-T-cell treatment to provide sustained HIV remission.
Hang SuApril MuellerHarris Goldstein
Published in: Current opinion in HIV and AIDS (2024)
Anti-HIV CAR-T cells can be engineered to provide potent and sustained in-vitro and in-vivo antiviral function. The combination of anti-HIV CAR-T cells with other immunotherapeutics may contribute to long-term HIV remission in PLWH.